Rakovina Therapeutics Inc (RKV) — Financial Flexibility Index
Rakovina Therapeutics Inc (RKV) has a Financial Flexibility Index of -0.31x as of September 2025. Free cash flow of CA$-1.04 Million (operating CF CA$-1.04 Million minus capex CA$0.00) represents 0% of total liabilities (CA$3.38 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rakovina Therapeutics Inc Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Rakovina Therapeutics Inc across 4 annual periods. See RKV net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rakovina Therapeutics Inc (2021–2024)
Year-by-year free cash flow to debt coverage for Rakovina Therapeutics Inc. For the full company profile including market capitalisation, see Rakovina Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.99x | CA$-3.86 Million | CA$-3.86 Million | CA$1.94 Million | ▼ -58.6% |
| 2023 | -1.25x | CA$-1.86 Million | CA$-1.86 Million | CA$1.49 Million | ▲ +93.0% |
| 2022 | -17.91x | CA$-1.92 Million | CA$-1.92 Million | CA$107.05K | ▲ +11.6% |
| 2021 | -20.25x | CA$-2.31 Million | CA$-2.31 Million | CA$113.98K | — |